Australian smokers' use of bupropion and nicotine replacement therapies and their relation to reimbursement, Australia 2001-05

Drug and Alcohol Review

Volumn 27, Issue 2, 2008, Pages 160-164

  Lutsenko, Hera ^a   Doran, Christopher M ^a,b   Hall, Wayne D ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b School of Economics ^*  (Australia)

Author keywords

Australian smokers; bupropion hydrochloride; nicotine replacement therapies

Indexed keywords

AMFEBUTAMONE; DOPAMINE UPTAKE INHIBITOR; NICOTINE; NICOTINIC AGENT;

ARTICLE; AUSTRALIA; DRUG THERAPY; ECONOMICS; FEMALE; HEALTH CARE COST; HUMAN; INCIDENCE; INTRADERMAL DRUG ADMINISTRATION; MALE; METHODOLOGY; MIDDLE AGED; PREVALENCE; REIMBURSEMENT; SMOKING; SMOKING CESSATION; STATISTICS; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, TOPICAL; AUSTRALIA; BUPROPION; DOPAMINE UPTAKE INHIBITORS; DRUG THERAPY; FEMALE; HEALTH EXPENDITURES; HUMANS; INCIDENCE; INSURANCE, HEALTH, REIMBURSEMENT; MALE; MIDDLE AGED; NICOTINE; NICOTINIC AGONISTS; PREVALENCE; SMOKING; SMOKING CESSATION;

EID: 38949178745     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1080/09595230701829462     Document Type: Article

References (24)

1. Australian Institute of Health and Welfare (AIHW). 2004 National Drug Strategy Household Survey. Canberra: AIHW, 2005.
2. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. Br Med J 2004;328:1519-27.
3. Ridolfo B, Stevenson C. Qualification of drug-caused mortality and morbidity in Australia. Canberra: Australian Institute of Health and Welfare, 2001.
4. Collins D, Lapsley H. Counting the cost: estimates of the social costs of drug abuse in Australia in 1998 - 9. Canberra: Commonwealth Department of Health and Ageing, 2002.
5. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev 2007;Issue 1:CD000031.
6. Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2004;Issue 3:CD000146.
7. Song F, Raftery J, Aveyard P, Hyde C, Barton P, Woolacott N. Cost-effectiveness of pharmacological interventions for smoking cessation: a literature review and a decision analytic analysis. Med Decis Making 2002;22(Suppl 5):S26-37.
8. Fagerstrom KO. Nicotine-replacement therapies. In: Ferrence R, Slade J, Room R, Pope M, eds. Nicotine and public health. Washington, DC: American Public Health Association, 2000:199-207.
9. Balfour DJ. The neurobiology of tobacco dependence: a commentary. Respiration 2002;69:7-11.
10. MIMS Online. Zyban SR. Sydney: HCN, 2005.
11. Medicare Australia. Pharmaceutical Benefits Scheme - PBS. Medicare Aust 2005. Available at: http://www.medicareaustralia.gov.au/yourhealth/our_services/ pbs.htm (accessed January 2006).
12. Herald-Sun. Zyban Involved in Many Overdoses. Herald- Sun 2002; 8 March, p. 13.
13. Higgins D, Pollard R. Smokers quit. ..their anti-smoking drugs. Sydney Morning Herald 2002; 10 September, p. 4.
14. Nankervis D. Rush to quit-smoking pill. Sunday Mail 2001; 11 February, p. 13.
15. Canberra Times. Demand and Concern for New Anti-Smoking Drug. Canberra Times 2001; 20 February, p. 3.
16. Gosch E. Fed - new drugs cause $450 m blow out in PBS. Australian Associated Press 2001; 29 May.
17. Australian Institute of Health and Welfare (AIHW). Australia's Health 2004. Canberra: AIHW, 2004.
18. Post-Standard. Safety tips: senior citizens and drugs. Post-Standard 2002; 4 April, p. 9.
19. Stock S. New pill to ease pain of giving up smoking. Australian 2000; 9 November, p. 7.
20. Hailstone B. Anti-smoke drug alert as 19 die. Adelaide Advertiser 2001; 20 February, p. 9.
21. Daily Telegraph. Slump after drug scare. Daily Telegraph 2002; 7 June, p. 21.
22. Shanahan M, Doran C, Stafford J, Shearer J, Mattick R. Pharmacotherapies for nicotine dependence: social and economic considerations. Sydney: National Drug and Alcohol Research Centre, University of New South Wales, 2004.
23. Therapeutic Goods Administration (TGA). Bupropion (Zyban SR). Therapeutic Goods Administration, Department of Health and Ageing, 2001. Available at: www.tga.gov.au/docs/html/zyban.htm (accessed January 2006).
24. MIMS Online. NicabateCQ and NicabateCQ Clear. Sydney: HCN, 2005.